A Phase 2b, Randomized, Controlled Trial Evaluating GS-5806 in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 28 Mar 2023

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

07 Feb 2023 Results assessing the RSV fusion inhibitor presatovir in RSV-infected lung transplant recipients, published in the Journal of Heart and Lung Transplantation.
18 Feb 2020 Results of pooled analysis assessing drug resistance from four phase IIb studies including this study published in the Antimicrobial Agents and Chemotherapy.
07 Oct 2018 Results of a combined resistance analyses from this and three other phase 2b studies, presented at the IDWeek 2018.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com